Can Monsel's Transmit Nosocomial Infections? A Microbiological Investigation

Audrey P Garrett1, Robert M Wenham, Andrew B Onderdonk

  • 1Division of Gynecologic Oncology, Departments of Obstetrics and Gynecology and Microbiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Insights

Monsel's paste, a topical hemostatic agent, effectively inhibits the growth of common nosocomial pathogenic bacteria. This study demonstrates that Monsel's solution is unlikely to be contaminated by bacteria, preventing infection transmission.

Area of Science:

  • Microbiology
  • Clinical Medicine
  • Pharmacology

Background:

  • Nosocomial infections pose a significant threat in healthcare settings.
  • Monsel's paste (20% ferric subsulfate) is a widely used topical astringent for hemostasis.
  • The potential for contamination of topical agents is a clinical concern.

Purpose of the Study:

  • To determine if common nosocomial pathogenic bacteria can survive and proliferate in Monsel's paste.
  • To assess the risk of Monsel's paste acting as a vector for infection transmission.

Main Methods:

  • Bacterial cultures were plated on various media with and without Monsel's paste.
  • Thioglycollate medium was used to test bacterial viability in combination with Monsel's paste.
  • Specific bacterial strains (Pseudomonas aeruginosa, Clostridium perfringens) were exposed to Monsel's paste and monitored for survival at timed intervals.

Main Results:

  • No bacterial growth was observed in open or inoculated samples of Monsel's paste.
  • Bacteria exposed to Monsel's paste showed no survival after 5 minutes.
  • The solution demonstrated potent antimicrobial properties against tested nosocomial pathogens.

Conclusions:

  • Monsel's paste exhibits significant antimicrobial activity, preventing the survival of nosocomial bacteria.
  • The risk of Monsel's paste contamination is negligible.
  • The potential for transmission of infection via Monsel's paste is improbable.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...